Characterizing drug resistance in hypoxia-adapted chronic myeloid leukaemia cells.
The development of tyrosine kinase inhibitors (TKI) has improved treatment of chronic myeloid leukaemia (CML) but resistance is observed in patients with advanced-stage CML. Second-generation TKIs overcome most resistance mechanisms but are ineffective against quiescent and hypoxic CML stem cells. M...
Saved in:
Main Author: | Muhammad Rauzan Rafman. |
---|---|
Other Authors: | School of Biological Sciences |
Format: | Final Year Project |
Language: | English |
Published: |
2013
|
Subjects: | |
Online Access: | http://hdl.handle.net/10356/52743 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
SRSF1-MEDIATED TYROSINE KINASE INHIBITOR RESISTANCE IN CHRONIC MYELOID LEUKAEMIA
by: SINNAKANNU JOANNA RAJESWARY
Published: (2018) -
MECHANISMS OF HYPOXIA-INDUCED GROWTH AND TYROSINE KINASE INHIBITOR RESISTANCE IN CHRONIC MYELOID LEUKEMIA
by: MANJERI ADITI SUBRAMANIAM
Published: (2019) -
Rac inactivation decreases cell adhesion strength in chronic myeloid leukaemia
by: Yang, Joan Xiaohui
Published: (2011) -
Transcriptional variation in human malaria parasites and its association with drug resistance
by: Mok, Sachel
Published: (2013) -
The cellular thermal shift assay : a novel strategy to study drug target engagement and resistance development in cancer therapy
by: Usha Sreekumar Lekshmy Kunjamma
Published: (2018)